Journal of Aging Science

Aging and the Immune System: Immunosenescence and Vaccine Response

Rachel Howell^* Department of Neuroscience, University of Florida, Gainesville, Florida, USA
^*Correspondence: Rachel Howell, Department of Neuroscience, University of Florida, Gainesville, Florida, USA, Email:

Received: 27-Feb-2025, Manuscript No. JASC-25-28491; Editor assigned: 01-Mar-2025, Pre QC No. JASC-25-28491 (PQ); Reviewed: 07-Mar-2025, QC No. JASC-25-28491; Revised: 14-Mar-2025, Manuscript No. JASC-25-28491 (R); Published: 28-Mar-2025, DOI: 10.35248/2329-8847.25.13.403

Description

Aging is accompanied by a gradual decline in immune function, a process known as immunosenescence. This phenomenon affects both innate and adaptive immunity, leading to increased susceptibility to infections, chronic inflammation and reduced vaccine efficacy. Understanding the mechanisms underlying immunosenescence and exploring strategies to enhance immune responses in older adults is important for improving health outcomes and extending lifespan [1].

Immunosenescence: Mechanisms and consequences Immunosenescence results from cumulative biological changes that impair immune cell function, leading to diminished responses to pathogens and vaccines.

Innate immunity decline: Altered macrophage and neutrophil function: Aging reduces phagocytic activity, delaying pathogen clearance and increasing infection susceptibility.

Reduced Natural Killer (NK) cell cytotoxicity: NK cells become less effective at targeting infected or malignant cells, weakening immune surveillance [2].

Chronic inflammation (Inflammaging): Age-related systemic inflammation, driven by persistent activation of inflammatory pathways, contributes to tissue damage and immune dysregulation.

Adaptive immunity impairments: Thymic involution and T cell reduction: The shrinking thymus leads to fewer naïve T cells, restricting the ability to combat novel pathogens.

Accumulation of senescent T cells: Aging results in an overrepresentation of memory T cells with reduced functionality, limiting immune flexibility [3].

Decline in B cell function: Aging decreases B cell diversity and antibody production, impairing humoral immunity and vaccine effectiveness.

Impact of immunosenescence on vaccine response

The aging immune system exhibits reduced responsiveness to vaccines, which has critical implications for public health, particularly for older adults susceptible to infectious diseases such as influenza, pneumococcal pneumonia and COVID-19.

Factors contributing to weakened vaccine efficacy:

Impaired antigen presentation: Reduced efficiency of dendritic cells results in suboptimal activation of T and B cells [4].

Lowered antibody production: Declining B cell responses lead to weaker and shorter-lived antibody-mediated immunity.

Delayed and weakened T cell responses: The diminished function of naïve T cells reduces the overall effectiveness of cellular immunity.

Inflammaging and immune dysregulation: Persistent low-grade inflammation interferes with vaccine-induced immune responses.

Strategies to enhance vaccine responses in older adults

To counteract immunosenescence, various strategies have been developed to optimize vaccine efficacy in aging populations.

Adjuvanted and high-dose vaccines: Adjuvants (e.g., MF59, AS03): These immune-stimulating compounds enhance antigen presentation and immune activation.

High-dose vaccines: Vaccines with increased antigen content (e.g., high-dose influenza vaccine) elicit stronger immune responses [5].

Booster vaccination strategies

Frequent boosters: Additional vaccine doses help reinforce immunity in older adults with waning immune memory.

Heterologous boosting: Using different vaccine formulations may enhance broad immune protection [6,7].

Lifestyle and nutritional interventions

Regular physical activity: Exercise enhances immune function and improves vaccine responses.

Adequate nutrition: Ensuring sufficient intake of protein, vitamins (e.g., D, C and E) and minerals (e.g., zinc) supports immune resilience [8].

Targeting inflammaging and immune modulation

Senolytics and anti-inflammatory agents: Removing senescent cells or reducing chronic inflammation may restore immune function.

Metformin and rapamycin: These drugs show potential in modulating immune aging and enhancing vaccine responses [9,10].

Conclusion

Aging leads to immunosenescence, which diminishes immune responses and reduces vaccine efficacy. However, targeted interventions, including advanced vaccine formulations, booster strategies, lifestyle modifications and immune-modulating therapies, offer potential methods for mitigating these effects. Continued research in immunology and aging will be critical in developing innovative solutions to protect the elderly from infectious diseases and improve overall health outcomes.

References

1. Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence and human vaccine immune responses. Immun Ageing. 2019;16:1-6.

   [Crossref] [Google Scholar] [PubMed]

2. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res. 2009;21:201-209.

   [Crossref] [Google Scholar] [PubMed]

3. Pera A, Campos C, López N, Hassouneh F, Alonso C, Tarazona R, et al. Immunosenescence: Implications for response to infection and vaccination in older people. Maturitas. 2015;82(1):50-55.

   [Crossref] [Google Scholar] [PubMed]

4. Boraschi D, Italiani P. Immunosenescence and vaccine failure in the elderly: Strategies for improving response. Immunol Lett. 2014;162(1):346-353.

   [Crossref] [Google Scholar] [PubMed]

5. Pereira B, Xu XN, Akbar AN. Targeting inflammation and immunosenescence to improve vaccine responses in the elderly. Front Immunol. 2020;11:583019.

   [Crossref] [Google Scholar] [PubMed]

6. Agrawal A, Weinberger B. The impact of immunosenescence and senescence of immune cells on responses to infection and vaccination. Front Aging. 2022;3:882494.

   [Crossref] [Google Scholar] [PubMed]

7. Allen JC, Toapanta FR, Chen W, Tennant SM. Understanding immunosenescence and its impact on vaccination of older adults. Vaccine. 2020;38(52):8264-8272.

   [Crossref] [Google Scholar] [PubMed]

8. Pawelec G, Adibzadeh M, Pohla H, Schaudt K. Immunosenescence: Ageing of the immune system. Immunol Today. 1995;16(9):420-422.

   [Crossref] [Google Scholar] [PubMed]

9. Lord JM. The effect of aging of the immune system on vaccination responses. Hum Vaccin Immunother. 2013;9(6):1364-1367.

   [Crossref] [Google Scholar] [PubMed]

10. Haq K, McElhaney JE. Immunosenescence: Influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38-42.

    [Crossref] [Google Scholar] [PubMed]